Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1


Figure 1 Binding of VEGF Family Members to 3 High-Affinity Receptors on Endothelium and Downstream Signaling Cascades

The roles of vascular endothelial growth factor receptor (VEGFR)-2 and -3 as principal regulators of blood and lymphatic vessel effects of vascular endothelial growth factors (VEGFs) are well established, but the biology of VEGFR-1 is still poorly understood. VEGFR-1 appears to mediate ligand-specific actions. It also exists as a soluble decoy receptor and acts as a negative regulator of angiogenesis. However, VEGFR-1 activation by placental growth factor (PlGF) and VEGF-B stimulates vascular growth and may result in the mobilization of EPCs in vivo. VEGFR-1 also mediates monocyte chemotaxis. Neuropilin-1 and -2 are co-receptors for some VEGFs and amplify intracellular signals. Affinity to heparan sulfates and neuropilin co-receptors modulate the biological activities of different VEGFs. VEGF-C and -D are proteolytically processed into mature forms that also effectively bind to VEGFR-2. DAG = diacylglycerol; eNOS = endothelial nitric oxide synthase; EPC = endothelial precursor cell; IP3 = inositol trisphosphate; MAPK = mitogen-activated protein kinase; NO = nitric oxide; NRP = neuropilin; PGI2 = prostacyclin; PKC = protein kinase C; PLC{gamma} = phospholipase gamma.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement